Breaking News

FDA Warns of Problems for Some Taking Hep C Drugs


liver anatomy illustration

Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the FDA warned Wednesday.

Comments